Forsta Ap Fonden Vertex Pharmaceuticals Inc Transaction History

Forsta Ap Fonden

$13.7 Billion
Q4 2024

A detailed history of Forsta Ap Fonden transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 58,700 shares of VRTX stock, worth $25.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

58,700

Previous 59,900 2.0%

Holding current value

$25.8 Million

Previous $27.9 Million 15.15%

% of portfolio

0.17%

Previous 0.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$396.64 - $516.74 $475,968 - $620,088	-1,200 Reduced 2.0%	58,700 $23.6 Million
Q3 2024 Oct 24, 2024	BUY	$460.0 - $505.78 $2.76 Million - $3.03 Million	6,000 Added 11.13%	59,900 $27.9 Million
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $707,058 - $873,954	-1,800 Reduced 3.23%	53,900 $25.3 Million
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $7.34 Million - $8.03 Million	-18,000 Reduced 24.42%	55,700 $23.3 Million
Q4 2023 Feb 06, 2024	BUY	$343.0 - $410.68 $205,800 - $246,408	600 Added 0.82%	73,700 $30 Million
Q3 2023 Oct 25, 2023	BUY	$338.18 - $362.46 $338,180 - $362,460	1,000 Added 1.39%	73,100 $25.4 Million
Q2 2023 Aug 03, 2023	BUY	$314.42 - $351.91 $754,608 - $844,584	2,400 Added 3.44%	72,100 $25.4 Million
Q1 2023 Apr 21, 2023	BUY	$283.23 - $323.1 $2.35 Million - $2.68 Million	8,300 Added 13.52%	69,700 $22 Million
Q4 2022 Feb 02, 2023	BUY	$285.76 - $321.48 $1.89 Million - $2.12 Million	6,600 Added 12.04%	61,400 $17.7 Million
Q3 2022 Oct 17, 2022	BUY	$273.83 - $305.53 $246,447 - $274,977	900 Added 1.67%	54,800 $15.9 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $845,856 - $1.05 Million	-3,600 Reduced 6.26%	53,900 $15.2 Million
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $4.38 Million - $5.17 Million	-19,800 Reduced 25.61%	57,500 $15 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $194,711 - $245,795	1,100 Added 1.44%	77,300 $17 Million
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $380,919 - $426,279	-2,100 Reduced 2.68%	76,200 $13.8 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $3.43 Million - $4.05 Million	18,300 Added 30.5%	78,300 $15.8 Million
Q1 2021 May 11, 2021	SELL	$207.02 - $241.31 $2.34 Million - $2.73 Million	-11,300 Reduced 15.85%	60,000 $12.9 Million
Q4 2020 Feb 09, 2021	BUY	$207.01 - $276.09 $2.67 Million - $3.56 Million	12,900 Added 22.09%	71,300 $16.9 Million
Q3 2020 Oct 22, 2020	BUY	$255.65 - $303.1 $5.91 Million - $7 Million	23,100 Added 65.44%	58,400 $15.9 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $901,920 - $1.18 Million	4,000 Added 12.78%	35,300 $10.2 Million
Q1 2020 May 04, 2020	BUY	$199.77 - $247.81 $6.25 Million - $7.76 Million	31,300 New	31,300 $7.45 Million

Others Institutions Holding VRTX

# of Institutions

1,708

Shares Held

220M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account